Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 31 (2), 187-94

Unifi Nootropics From the Lab to the Web: A Story of Academic (And Industrial) Shortcomings

Affiliations
Review

Unifi Nootropics From the Lab to the Web: A Story of Academic (And Industrial) Shortcomings

Fulvio Gualtieri. J Enzyme Inhib Med Chem.

Abstract

This paper is a review of the work of my former academic group of research in the past 15 years, in the field of cognition enhancers (also called nootropics) that identified two very potent molecules: Unifiram and Sunifiram that for a variety of reasons were not protected by a patent. Some 12 years after their disclosure (2000) I casually found that on the web, there were dozens of sites offering Unifiram and Sunifiram as drugs that improve cognition in healthy individuals even if only few preclinical studies were done and their long-term toxicity was unknown.

Keywords: Cognition enhancers; Sunifiram; Unifiram; online drug market.

Similar articles

See all similar articles

LinkOut - more resources

Feedback